Author Interviews, Hepatitis - Liver Disease / 26.04.2013
A risk for hepatocellular carcinoma still persists long-term after sustained virological response in patients with hepatitis C associated liver cirrhosis
MedicalResearch.com: eInterview with: Soo Aleman
Department of Gastroenterology and Hepatology, and Infectious Diseases
Karolinska University Hospital, at Karolinska Institute
171 76 Stockholm, Sweden,
MedicalResearch.com: What are the main findings of the study?
Answer: In this long-term, prospective study of 351 hepatitis C infected patients with liver cirrhosis, we found a reduced but persistent risk for hepatocellular cancer after successful treatment with eradication of the virus. This risk for hepatocellular cancer remained at a level of 1% per year for those with sustained virological response, and could persist as long as 8 years after eradication.
(more…)